The TRIUMPH programme spans 5,800+ participants across four global registrational trials, covering obesity, type 2 diabetes, knee osteoarthritis, sleep apnoea, chronic low back pain, and MASLD
The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice
Semaglutide with the maximum dose of 2.4 mg (Wegovy) was not available in Austria at the time of enrollment
At Ishin, we focused on: natural fermentation, stability, proper packaging, and verified manufacturing
[2] The lower headline number in REDEFINE 2 than in REDEFINE 1 is the expected pattern weight loss is typically smaller in populations with type 2 diabetes and is a good reminder that a trials population matters as much as its drug
10.3390/toxins8110326 77 VernonG.BaranovaA.YounossiZ